A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

计划入组 467 人 · 首次发布于 2024 年 9 月 3 日

A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

计划入组 75 人 · 首次发布于 2023 年 5 月 23 日

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients

计划入组 9 人 · 首次发布于 2024 年 10 月 1 日

HNF4α srRNA

HNF4alpha srRNA therapy

JCXH-105

AIM VACCINE

China

Finlay Vaccine Institute

Path Vaccine Solutions

United States

Replicate Bioscience's Novel srRNA Rabies Vaccine Shows Promise in First Human Trial

Replicate Bioscience Partners with Instituto Butantan to Advance Self-Replicating RNA Rabies Vaccine in Latin America

Replicate Bioscience's Self-Replicating RNA Rabies Vaccine Shows Superior Durability in Phase I Trial